Mythic Therapeutics

About:

Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.

Website: http://www.mythictx.com

Top Investors: BoxGroup, Perceptive Advisors, Venrock, Foresite Capital, Viking Global Investors

Description:

Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics. The company is pioneering a powerful protein engineering-focused approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Their technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets.

Total Funding Amount:

$127M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2017-01-01

Founders:

Alex Nichols, Brian Fiske, Nimish Gera

Number of Employees:

11-50

Last Funding Date:

2021-12-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai